{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:03:33Z","timestamp":1781327013658,"version":"3.54.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>As the SARS-CoV2 pandemic has progressed, there have been marked geographical differences in the pace and extent of its spread. We evaluated the association of BCG vaccination on morbidity and mortality of SARS-CoV2, adjusted for country-specific responses to the epidemic, demographics and health. SARS-CoV2 cases and deaths as reported by 31 May 2020 in the World Health Organization situation reports were used. Countries with at least 28 days following the first 100 cases, and available information on BCG were included. We used log-linear regression models to explore associations of cases and deaths with the BCG vaccination policy in each country, adjusted for population size, gross domestic product, proportion aged over 65 years, stringency level measures, testing levels, smoking proportion, and the time difference from date of reporting the 100th case to 31 May 2020. We further looked at the association that might have been found if the analyses were done at earlier time points. The study included 97 countries with 73 having a policy of current BCG vaccination, 13 having previously had BCG vaccination, and 11 having never had BCG vaccination. In a log-linear regression model there was no effect of country-level BCG status on SARS-CoV2 cases or deaths. Univariable log-linear regression models showed a trend towards a weakening of the association over time. We found no statistical evidence for an association between BCG vaccination policy and either SARS-CoV2 morbidity or mortality. We urge countries to rather consider alternative tools with evidence supporting their effectiveness for controlling SARS-CoV2 morbidity and mortality.<\/jats:p>","DOI":"10.1371\/journal.pone.0243707","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T21:19:25Z","timestamp":1608239965000},"page":"e0243707","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0083-8319","authenticated-orcid":true,"given":"Lucy","family":"Chimoyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavindhran","family":"Velen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J.","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"pone.0243707.ref001","unstructured":"World Health Organization. COVID-19 situation report 157 [2020 Jun 25]. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200625-covid-19-sitrep-157.pdf?sfvrsn=423f4a82_2. Geneva: WHO, 2020."},{"issue":"5","key":"pone.0243707.ref002","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","article-title":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","volume":"20","author":"A Wilder-Smith","year":"2020","journal-title":"The Lancet Infectious diseases"},{"issue":"1","key":"pone.0243707.ref003","doi-asserted-by":"crossref","first-page":"e0226803","DOI":"10.1371\/journal.pone.0226803","article-title":"Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans","volume":"15","author":"LP Zhao","year":"2020","journal-title":"PloS one"},{"issue":"12","key":"pone.0243707.ref004","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"S Moorlag","year":"2019","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"3","key":"pone.0243707.ref005","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Datau EA Wardhana","year":"2011","journal-title":"Acta medica Indonesiana"},{"issue":"9","key":"pone.0243707.ref006","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/adc.2009.157537","article-title":"The non-specific effects of vaccines","volume":"95","author":"F Shann","year":"2010","journal-title":"Archives of disease in childhood"},{"issue":"2","key":"pone.0243707.ref007","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"F Shann","year":"2013","journal-title":"Clinical therapeutics"},{"issue":"2","key":"pone.0243707.ref008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"E Nemes","year":"2018","journal-title":"The New England journal of medicine"},{"issue":"3","key":"pone.0243707.ref009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"G Redelman-Sidi","year":"2014","journal-title":"Nature reviews Urology"},{"key":"pone.0243707.ref010","author":"A Shet","year":"2020","journal-title":"Differential COVID-19-attributable mortality and BCG vaccine use in countries"},{"key":"pone.0243707.ref011","author":"G Sala","year":"2020","journal-title":"Association of BCG vaccination policy with prevalence and mortality of COVID-19"},{"key":"pone.0243707.ref012","author":"A Miller","year":"2020","journal-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study"},{"issue":"3","key":"pone.0243707.ref013","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"A Zwerling","year":"2011","journal-title":"PLoS medicine"},{"key":"pone.0243707.ref014","unstructured":"Pai M. BCG Against Coronavirus: Less Hype And More Evidence, Please. https:\/\/www.forbes.com\/sites\/madhukarpai\/2020\/04\/12\/bcg-against-coronavirus-less-hype-and-more-evidence-please\/#78f78ca26b4f. Accessed on 22 July 2020: Forbes Media LLC; 2020. https:\/\/www.forbes.com\/sites\/madhukarpai\/2020\/04\/12\/bcg-against-coronavirus-less-hype-and-more-evidence-please\/#163336dc6b4f."},{"key":"pone.0243707.ref015","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation reports. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports. Accessed on 17 May 2020. Geneva, Switzerland: WHO, 2020."},{"key":"pone.0243707.ref016","unstructured":"Worldometer. Coronavirus Testing: Criteria and Numbers by Country. at https:\/\/www.worldometers.info\/coronavirus\/covid-19-testing\/. Accessed on 06 June 2020: Worldometer 2020. https:\/\/www.worldometers.info\/coronavirus\/covid-19-testing\/."},{"key":"pone.0243707.ref017","unstructured":"A Database of Global BCG Vaccination Policies and Practices 2nd edition [Internet]. McGill University. 2017. http:\/\/bcgatlas.org\/index.php."},{"key":"pone.0243707.ref018","unstructured":"WHO and Unicef estimates of Immunization schedule 2020. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/lbn.pdf."},{"key":"pone.0243707.ref019","unstructured":"ECDC. Tuberculosis: Recommended vaccinations 2020. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler."},{"key":"pone.0243707.ref020","unstructured":"Thomas H, Webster S, Petherick A, Phillips T, B. K. Oxford COVID-19 Government Response Tracker, Blavatnik School of Government. Data use policy: Creative Commons Attribution CC BY standard. https:\/\/www.bsg.ox.ac.uk\/research\/research-projects\/coronavirus-government-response-tracker. Accessed on 02 June 2020 United Kingdom: Blatnavik School of Goverment, Oxford University; 2020. https:\/\/www.bsg.ox.ac.uk\/research\/research-projects\/coronavirus-government-response-tracker."},{"key":"pone.0243707.ref021","unstructured":"World Health Organization. Global Health Observatory data repository. https:\/\/apps.who.int\/gho\/data\/view.main. Accessed on 12 June 2020 Geneva, Switzerland: World Health Organization; 2020. https:\/\/apps.who.int\/gho\/data\/node.main.65."},{"key":"pone.0243707.ref022","unstructured":"World Health Organization. Global Tuberculosis Report. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329368\/9789241565714-eng.pdf?ua=1. Accessed on 16 July 2020. Geneva, Switzerland: World Health Organization, 2019."},{"key":"pone.0243707.ref023","unstructured":"StataCorp. Release 15 ed. College Station, TX: StataCorp LP; 2014. p. Stata Statistical Software."},{"key":"pone.0243707.ref024","unstructured":"Environmental Systems Research Institute. ArcGIS Release. 10.7.1 ed. Redlands, CA.: ESRI; 2019."},{"key":"pone.0243707.ref025","article-title":"BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden","author":"C de Chaisemartin","year":"2020","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"22","key":"pone.0243707.ref026","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults","volume":"323","author":"U Hamiel","year":"2020","journal-title":"Jama"},{"issue":"41","key":"pone.0243707.ref027","doi-asserted-by":"crossref","first-page":"25203","DOI":"10.1073\/pnas.2016733117","article-title":"Lack of evidence for BCG vaccine protection from severe COVID-19","volume":"117","author":"CS Lindestam Arlehamn","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"pone.0243707.ref028","first-page":"207","article-title":"Stop playing with data: there is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"M Ricc\u00f2","year":"2020","journal-title":"Acta Biomed"},{"key":"pone.0243707.ref029","article-title":"Bacille Calmette-Gu\u00e9rin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed","author":"H. S Schaaf","year":"2020","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"pone.0243707.ref030","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","author":"J Tian","year":"2020","journal-title":"The Lancet Oncology"},{"key":"pone.0243707.ref031","article-title":"National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19","author":"R Ebina-Shibuya","year":"2020","journal-title":"Respirology"},{"issue":"6","key":"pone.0243707.ref032","doi-asserted-by":"crossref","first-page":"e12661","DOI":"10.15252\/emmm.202012661","article-title":"Is BCG vaccination causally related to reduced COVID-19 mortality?","volume":"12","author":"M Miyasaka","year":"2020","journal-title":"EMBO Mol Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T21:20:02Z","timestamp":1608240002000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243707"}},"subtitle":[],"editor":[{"given":"Angelo A.","family":"Izzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243707","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]}}}